NEW YORK (GenomeWeb) – Bioinformatics firm Sophia Genetics today announced deals with the UK's National Health Service and an unnamed Turkish laboratory to provide them access to the company's data-driven medicine platform.

The platform offers a secure software-as-a-service module for the analysis, validation, quality control, and presentation of genetic tests to clinicians, as well as storage and data sharing capabilities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.